The qualitative problem of major quotation errors, as illustrated by 10 different examples in the headache literature

Headache

Volumn 55, Issue 3, 2015, Pages 419-426

  Tfelt Hansen, Peer ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

headache literature; quotation error; suggestion to decrease problem

Indexed keywords

ACETYLSALICYLIC ACID; METOCLOPRAMIDE; SUMATRIPTAN;

AUTHOR; DRUG EFFICACY; HEADACHE; HUMAN; IN VITRO STUDY; MEDICAL LITERATURE; MENINGEAL ARTERY; MIDDLE MENINGEAL ARTERY; MIGRAINE; PHARMACOKINETICS; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUOTATION ERROR; REFERENCE DATABASE; RELIABILITY; REPRODUCIBILITY; REVIEW; STATISTICAL PARAMETERS; FEMALE; MALE; PEER REVIEW; PUBLICATION; PUBLISHING; QUALITY CONTROL; RETROSPECTIVE STUDY; STANDARDS;

FEMALE; HEADACHE; HUMANS; JOURNALISM, MEDICAL; MALE; PEER REVIEW, RESEARCH; PERIODICALS AS TOPIC; QUALITY CONTROL; RETROSPECTIVE STUDIES;

EID: 84924414852     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/head.12529     Document Type: Review

References (46)

1. de Lacey G, Record C, Wade J,. How accurate are quotations and references in medical journals? BMJ. 1985; 291: 884-886.
2. Neihouse PF, Priske SC,. Quotation accuracy in review articles. DICP. 1989; 23: 594-596.
3. Kolbitsch C, Hörmann C, Benzer A,. Quotation accuracy in neuroanesthesiologic research. J Neurosurg Anesthesiol. 1977; 9: 8-10.
4. Callaham M, Wears RL, Weber E,. Journal prestige, publication bias, and other characteristics associated with citation of published studied in peer-reviewed journals. JAMA. 2002; 287: 2487-2850.
5. Gosling CM, Cameron M, Gibbons PF,. Referencing and quotation accuracy in four manual therapy journals. Man Ther. 2004; 9: 36-40.
6. Buchan JC, Norris J, Kuper H,. Accuracy of referring in the ophthalmic literature. Am J Ophthalmol. 2005; 140: 1146-1148.
7. Reddy MS, Srinivas S, Sabanaygam N, Balasubramanian SP,. Accuracy of references in general surgical journals-an old problem revisited. Surgeon. 2008; 6: 71-75.
8. Davids JR, Weighl DM, Edmonds JP, Blackhurst DW,. Reference accuracy in peer-reviewed pediatric orthopaedic literature. J Bone Joint Surg Am. 2010; 92: 1155-1161.
9. Luo M, Li CC, Molina D, Andersen CR, Panchbhavi VK,. Accuracy of citation and quotation in foot and ankle surgery journals. Foot Ankle Int. 2013; 34: 949-955.
10. Wager E, Middleton P,. Technical editing of research reports in biomedical journals (reviews). Cochrane Database Syst Rev. 2008;(4): MR000002.
11. Tfelt-Hansen P, Rosenberg J,. Essential problems with references in the medical literature. Ugeskr Laeger. 2013; 175: 2019. (Danish).
12. Nagata E, Moriguchi H, Takizawa S, et al. The middle meningeal artery during a migraine attack: 3T magnetic resonance angiography study. Intern Med. 2009; 48: 2133-2135.
13. Saper JR, Silberstein S,. Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine. Headache. 2006; 46 (Suppl. 4): S171-S181.
14. Humbert H, Cabiac MD, Dubray C, Lavéne D,. Human pharmacokinetics of dihydroergotamine administered by nasal spray. Clin Pharmacol Ther. 1996; 60: 265-275.
15. Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan in the acute treatment of migraine. Eur Neurol. 1991; 31: 314-322.
16. Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol. 1992; 32: 177-184.
17. Tunis MM, Wolff HG,. Long term observations of the reactivity of the cranial arteries in subjects with vascular headache of the migraine type. Arch Neurol Psychiatry. 1953; 70: 551-557.
18. Olesen J, Friberg L, Skyhoj-Olsen T, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol. 1990; 28: 791-798.
19. Graham JR, Wolff HG,. Mechanism of migraine headache and action of ergotamine. Arch Neurol Psychiatry. 1938; 39: 737-763.
20. Tfelt-Hansen PC, Koehler P,. History of the use of ergotamine and dihydroergotamine in migraine from1906 and forward. Cephalalgia. 2008; 28: 877-886.
21. Ray BS, Wolff HG,. Experimental studies on headache. Pain-sensitive structures of the head and their significance in headache. Arch Surg. 1940; 41: 813-856.
22. Meng ID, Bereiter DA,. Differential distribution of Fos-like immunoreactivity in the spinal trigeminal nucleus after noxious and innocuous thermal and chemical stimulation of rat cornea. Neuroscience. 1996; 72: 243-254.
23. Sugiyo S, Uehashi D, Satoh F, et al. Effects of systemic bicuculline or morphine on formalin-evoked pain-related behavior and c-Fos expression in trigeminal nuclei after formalin injection into the lip or tongue in rats. Exp Brain Res. 2009; 196: 229-237.
24. Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ,. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical cord following stimulation of the superior sagittal sinus in the cat. Brain Res. 1993; 629: 95-102.
25. Hoskin KL, Zagami AS, Goadsby PJ,. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: A comparative study of monkey and cat. J Anat. 1999; 194: 579-588.
26. Gallai V, Sarchielli P, Floridi A, et al. Vasoactive peptide levels in the plasma of young migraine patients with an without aura assessed both interictally and ictally. Cephalalgia. 1995; 15: 384-390.
27. Goadsby PJ, Edvinsson L, Ekman R,. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990; 28: 183-187.
28. Goadsby PJ, Edvinsson L,. The trigeminovascular system and migraine: Studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993; 33: 48-56.
29. Goadsby PJ, Edvinsson L,. Human in vivo evidence for trigeminovascular activation in cluster headache: Neuropeptide changes and effects of acute attacks therapies. Brain. 1994; 117: 427-434.
30. Tfelt-Hansen P,. Is orally inhaled dihydroergotamine (DHE) equivalent in efficacy in migraine to intravenous DHE? Headache. 2014; 54: 383.
31. Shrewsbury SB, Cook RO, Taylor G, Edwards C, Ramadan NM,. Safety of pharmacokinetics of dihydroergotamine mesylate administered via a novel (Tempo) inhaler. Headache. 2008; 48: 355-367.
32. Kurth T, Chabriat H, Bousser MG,. Migraine and stroke: A complex association with clinical implications. Lancet Neurol. 2012; 11: 92-100.
33. Etminan M, Takkouche B, Isorna FC, Samii A,. Risk of ischaemic stroke in people with migraine: Systematic review and meta-analysis of observational studies. BMJ. 2005; 330: 63. [Epub 2004 Dec 13].
34. Schurks M, Rist PM, Bigal ME, Buring JE, Lipton RB, Kurth T,. Migraine and cardiovascular disease: Systematic review and meta-analysis. BMJ. 2009; 339: b3914.
35. Spector JT, Kahn SR, Jones MR, Jayakumar M, Dalal D, Nazarian S,. Migraine headache and ischemic stroke risk: An updated meta-analysis. Am J Med. 2010; 123: 612-624.
36. Eichorn P, Yankauer A,. Do others check their references? A survey of accuracy of references in three public health journals. Am J Public Health. 1987; 77: 1011-1012.
37. Gupta P, Yadar M, Mohta A, Choudhury P,. References in Indian Pediatrics: Authors need to be accurate. Indian Pediatr. 2005; 42: 140-145.
38. Schoonman GG, van der Grond J, Kortman C, van der Geest RJ, Terwindt GM, Ferrari MD,. Migraine headache is not associated with cerebral or meningeal vasodilation-a 3T magnetic resonance angiography study. Brain. 2008; 131: 2192-2200.
39. Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K,. Effect of nitroglycerin on cerebral circulation measured by transcranial Doppler and SPECT. Stroke. 1989; 20: 1733-1736.
40. Hansen JM, Pedersen DI, Larsen VA, et al. Magnetic resonance angiography shows dilatation of middle cerebral artery after infusion of glyceryl trinitrate in healthy volunteers. Cephalalgia. 2007; 27: 118-127.
41. Dahl A, Russell D, Nyberg-Hansen R, Rootwelt K, Mowinchel P,. Simultaneous assessment of vasoreactivity using transcranial Doppler ultrasound and cerebral blood flow in healthy subjects. J Cereb Blood Flow Metab. 1994; 14: 974-981.
42. Schreiber SJ, Gottschalk S, Weih M, Villinger A, Valdueza M,. Assessment of blood flow velocity and diameter of the middle cerebral artery during acetazolamide provocation test by use of transcranial Doppler sonography and MR imaging. AJNR Am J Neuroradiol. 2000; 21: 1207-1211.
43. Angrim N, Schytz HW, Asghar MS, et al. Association of acetazolamide infusion with headache and cranial artery dilation in healthy volunteers. Pain. 2014; 155: 1649-1658.
44. Wolff HG,. Headache and Other Head Pain, 2nd edn. New York: Oxford University Press; 1963.
45. Denuelle M, Fabre N, Payoux P, Chollet F, Gerard G,. Posterior cerebral hypoperfusion in migraine without aura. Cephalalgia. 2008; 28: 856-862.
46. Sanchez del Rio M, Olesen J, Diner H-C,. Hemodynamics and neuroimaging of migraines. In:, Olesen J, Goadsby PJ, Ramadan NM, Tfelt-Hansen P, Welch KMA, eds. The Headaches, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins; 2006: 351-361.